Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aflibercept (zaltrap) (1 trial)
dexamethasone (1 trial)
ranibizumab (lucentis) (1 trial)
mycobacterium w vaccine (1 trial)
Macular Edema (Phase 4)
Trials (2 total)
Trial APIs (4 total)